Alice Tracey
@AliceTrace67285
Followers
91
Following
55
Statuses
21
Correspondent @Capitol_Forum reporting on competition and corporate conduct issues in health care and pharma
Washington, DC
Joined May 2023
RT @vikasxkumarbk: I read Teva's answer to $CORT's motion to dismiss last night. I thought the legal analysis of why Teva needs access to…
0
2
0
RT @Capitol_Forum: BIOSECURE Act Could Aid U.S. Contract Research Organizations Hurt by Monkey Supply Chain Disruption; Supporters Target P…
0
2
0
RT @51stnews: Three weeks ago, we publicly launched The 51st, and the immediate outpouring of support and enthusiasm for worker-led local n…
0
22
0
RT @Capitol_Forum: (2/2) Hospital Merger Law Advances in Pennsylvania, Home of UPMC $ABBV $CI $CVS $DVA $FMCQF $FME $FMS $FRE $GSK $HUM $LL…
0
1
0
Check out my work on a radiology company in CA
RadNet: Former Employees, Customers Raise Concerns About Radiology Roll-Up's Business Practices $RDNT h/t @AliceTrace67285
0
0
3
RT @TeddyDowney: From @Capitol_Forum on april 22. Wsj, politico, and bloomberg. Just casually 2+ months late.
0
11
0
Super proud of the work my team and I did on this story back in April!
Ay maybe you should read TCF, you'd get the news months before the big pubs. @AliceTrace67285
0
2
6
RT @dorajfacundo: I have to say it's very frustrating Express Scripts and the other companies featured in this investigation didn't respond…
0
8
0
Check out my work on how a major PBM prices and categorizes an otherwise inexpensive HIV prevention drug in Medicare Part D
EXCLUSIVE: Express Scripts is Gouging Medicare and Seniors on Generic HIV Prevention Drug @Capitol_Forum reports that Medicare Part D plans managed by pharmacy benefit manager Express Scripts charge some patients and the government more than $1,200 for a month's supply of generic Truvada, while the same drug costs under $20 online.
0
5
13
RT @dorajfacundo: EXCLUSIVE: Express Scripts is Gouging Medicare and Seniors on Generic HIV Prevention Drug @Capitol_Forum reports that Me…
0
43
0
RT @Capitol_Forum: Boehringer Ingelheim May Face Enhanced Legal Risk From FTC's Orange Book Crackdown $ABBV $AZN $GSK $SNY $TEVA h/t @Ali…
0
2
0
Check out my work on the group purchasing organization industry!
With Critics Alleging PBM-Like Tactics, GPOs Could Face Interest from Antitrust Enforcers $ABC $CAH $CI $COR $CVS $MCK $OSH $PINC $SGFY h/t @AliceTrace67285
0
3
12
RT @Capitol_Forum: With Critics Alleging PBM-Like Tactics, GPOs Could Face Interest from Antitrust Enforcers $ABC $CAH $CI $COR $CVS $MCK $…
0
1
0
RT @matthewstoller: The FTC in September started challenging illegal patents on inhalers and epipen auto-injectors. Today, Kaleo withdrew…
0
37
0
RT @Capitol_Forum: “Health Care Antitrust Weekly: FTC Pairs 'Killer Acquisition' Litigation vs. Sanofi/Maze with Clearance of Pfizer/Seagen…
0
3
0
RT @Capitol_Forum: "Drugmakers Who Verify Challenged Orange Book Listings Are Likely to Face Antitrust and Civil Racketeering Claims, Lawye…
0
3
0
Check out my work on the FTC's recent crackdown on Orange Book listings!
The @FTC has taken a hardline stance against improper Orange Book listings, challenging more than 100 patents held by brand-name drugmakers. In our article, we break down the legal and regulatory framework guiding the agency’s move: H/t @AliceTrace67285
0
1
10
RT @Capitol_Forum: "Health Care Antitrust Weekly: Ohio Continues to Lead on Pharmacy Industry Oversight; Hospitals Push "Clear-Bagging" in…
0
2
0
RT @Capitol_Forum: Asthma Inhalers Produced by AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Teva Could Face Near-Term Generic Com…
0
1
0
RT @LWadsten: Check out what @AliceTrace67285 and I have been working on to learn how drugmakers + #pbms are keeping patients from getting…
0
2
0